CNC

Centene Corp.

Healthcare, Event Driven/Special Sit


Presented:11/26/2019
Price:$60.47
Cap:$25.02B
Current Price:$68.48
Cap:$36.02B

Presented

Date11/26/2019
Price$60.47
Market Cap$25.02B
Ent Value$26.11B
P/E Ratio18.75x
Book Value$29.75
Div Yield0%
Shares O/S413.80M
Ave Daily Vol4,942,749
Short Int12.84%

Current

Price$68.48
Market Cap$36.02B
Centene Corp. engages in the provision of programs and services to government sponsored healthcare programs. It operates through the Managed Care and Specialty Services segments. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid. The Specialty Services segment offers healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company was founded in 1984 and is headquartered in St. Louis, MO.

Publicly traded companies mentioned herein: Centene Corp (CNC), Cigna Corporation (CI), Humana Inc (HUM), UnitedHealth Group (UNH), WellCare Health Plans, Inc (WCG)

Highlights

The presenter is long shares of Centene (CNC) as he believes the “Medicare For All” threat has significantly diminished. Recent sentiment shift against the managed care companies (Centene, Humana, Wellcare, etc.) reached a major turning point when Elizabeth Warren stated that the rollout process for the program would take 3 years. He views multiple positive catalysts going forward, namely, the removal of the “Medicare for All” overhang, the ACAs unconstitutionality ruling being overturned, and further expansion into high growth exchange business. CNC is currently trading at an 11x earnings multiple and the presenter sees a trajectory to $6 EPS in 2021. He believes the stock is lagging behind its peers, should trade closer to the sector’s average (~15x), and sees 50% upside from the current price of $60 to $80- $90.

As the largest Medicaid MCO in the US focused on low-income and high-risk populations, the presenter likes to think of Centene as “the UnitedHealth of Medicaid.” The company operates a full-service PBM (RxAdvance) and boasts a combination of assets similar to UnitedHealth’s model. As a result, as Centene expands into new regions through the ACA exchanges, it will be able to leverage provider networks successfully as it is geared towards this segment of the population. 

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Request access to DeMatteo Research for full access

Request Access

Already have an account?

Idea Discussion

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Idea Discussions display submitted commentary from our investor community.

To read and participate in the discussion with the presenter and investor base, request access to DeMatteo

Request Access

Already have an account?

An error occurred loading this content. Try again later or contact us.